High Dose SAB-142

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesNCT07187531SABSPhase 2Recruiting2027-11Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.